SomaLogic announced today that Board of Directors member Alister W. (Al) Reynolds has agreed to become the next company Chief Executive Officer. He is replacing Byron Hewett, who elected to step down from the role following several years of successfully leading the company through its initial growth into a successful commercial entity.
read moreNews Press Release Archive
News Archive
Modified DNA aptamers: Two is better than one
In a study published online in the Proceedings of the National Academy of Sciences (PNAS), SomaLogic scientists report on the generation and characterization of a new class of SOMAmer that contains two different types of modified nucleotides.
read moreSomaLogic announces that it has joined the iCarbonX Digital Life Alliance
SomaLogic announced today that it has agreed to join the “Digital Life Alliance” established by iCarbonX, the China-based company founded in 2015 to build a “Global Digital Health Ecosystem that can define each person’s ‘digital life’ based on a combination of individual’s biological, behavioral and psychological data, the Internet and artificial intelligence.”
read moreLevels of nine blood proteins can accurately predict high or low risk of serious cardiovascular events
A study published online today in the Journal of the American Medical Association (JAMA) details the first successful effort to measure at scale the levels of more than a thousand proteins in blood in patients with coronary heart disease, and describes the identification of a combination of nine specific proteins whose levels taken together can accurately predict the risk of future heart attacks, strokes, heart failure or death.
read moreSomaLogic announces SOMAscan assay deployment agreement with University College London
SomaLogic announced today that it has signed an agreement with University College London (UCL) to deploy SomaLogic’s proprietary SOMAscan assay in the UCL Genomics laboratory. This agreement marks the first placement of the assay in the University of London large network of self-governing colleges and research institutes.
read moreSomaLogic raises up to $60.5 million from Visium Healthcare Partners to support strategic growth initiatives
SomaLogic, Inc. and Visium Healthcare Partners, LP today announced that SomaLogic will receive up to $60.5 million through a combination of debt and equity financing from Visium. The proceeds will be used to support SomaLogic’s continued growth.
read moreThe University of Oxford and SomaLogic Announce wide-ranging agreement to use SOMAscan in translational research
The University of Oxford and SomaLogic announced today that they have agreed to undertake a number of collaborative projects that will employ SomaLogic’s proprietary SOMAmer reagents and SOMAscan assay technologies to discover and characterize protein biomarkers for a range of clinical diseases and conditions.
read moreMatthew (“Matt”) Norkunas, M.D., announced as new SomaLogic CFO
SomaLogic, Inc. announced today that Matthew Norkunas, M.D. has joined the company as Chief Financial Officer (CFO). Prior to SomaLogic, Dr. Norkunas was a Senior Research Analyst at Marsico Capital Management in Denver focused on biotech, pharma, life sciences, and diagnostics companies.
read moreSomaLogic completes agreement with Bristol-Myers Squibb for expanded access to SOMAmer reagents
SomaLogic, Inc. announced today that it signed an agreement with the Bristol-Myers Squibb Company (NYSE-BMY) to provide expanded access to its proprietary SOMAmer reagents. The agreement covers both the 1,310 reagents available in the current public version of the SOMAscan assay, as well as custom SOMAmer reagents developed through SomaLogic’s SOMAmer Discovery Service specifically for Bristol-Myers Squibb.
read moreVU University Medical Center Amsterdam Is First Continental European SOMAscan® Assay Site
SomaLogic, Inc. and VU University Medical Center Amsterdam (VUmc) announced today that the SOMAscan assay, a breakthrough proteomics platform, will be deployed at VUmc for its scientists’ use in multiple different biomedical research projects.
read more